Ionis Pharmaceuticals Inc (IONS): 8:03AM ISIS Pharm initiates Phase 2 stud...

Replies (1) Next 10 Prev Next

surf1944

Send PM Follow Ignore

Followers	467
Posts	26957
Boards Moderated	1
Alias Born	09/11/2006

surf1944

Re: surf1944 post# 247

Tuesday, 02/26/2013 9:02:58 AM

Tuesday, February 26, 2013 9:02:58 AM

8:03AM ISIS Pharm initiates Phase 2 study Of ISIS-CRP Rx In patients with atrial fibrillation (ISIS) 14.02 : Co announced the initiation of a Phase 2 study evaluating ISIS-CRPRx in patients with paroxysmal atrial fibrillation.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent IONS News

Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/23/2026 08:24:45 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2026 08:22:45 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2026 08:21:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2026 11:00:40 AM
Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting • Business Wire • 04/21/2026 11:00:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 11:19:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 11:19:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 11:19:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 11:19:15 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/16/2026 10:49:36 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/16/2026 10:47:56 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/16/2026 10:45:23 PM
Ionis to hold first quarter 2026 financial results webcast • Business Wire • 04/15/2026 11:05:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 11:43:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 11:43:36 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 09:28:08 PM
Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review • Business Wire • 03/23/2026 11:00:00 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/19/2026 08:01:25 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:32:31 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/10/2026 08:00:22 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/09/2026 08:16:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:00:45 AM
Ionis announces changes to Board of Directors • Business Wire • 03/09/2026 11:00:00 AM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent IONS News

More IONS News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent IONS News

Go Ad-Free